Silo Pharma, Inc. (SILO)

Silo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3	4	11	-	-	-
Market Cap Growth	-16.41%	-57.55%	-	-	-	-
Enterprise Value	-3	-3	-1	-10	-1	-0
PE Ratio	-	-1.21	-2.70	-	-	-
PS Ratio	48.32	62.09	146.27	-	-	-
PB Ratio	0.66	0.73	1.02	-	-	-
P/FCF Ratio	-1.65	-1.39	-3.02	-	-	-
P/OCF Ratio	-1.65	-1.39	-3.02	-	-	-
EV/Sales Ratio	-16.63	-44.22	-12.34	-143.93	-	-6.39
EV/EBITDA Ratio	0.33	0.86	0.23	-2.61	0.41	0.27
EV/EBIT Ratio	0.33	0.86	0.23	-2.61	0.41	0.27
EV/FCF Ratio	0.36	0.99	0.25	4.50	0.98	0.33
Debt / Equity Ratio	-	-	-	-	0.01	-2.70
Debt / EBITDA Ratio	-	-	-	-	-0.01	-0.07
Debt / FCF Ratio	-	-	-	-	-0.02	-0.08
Quick Ratio	7.72	9.88	26.21	20.93	8.13	2.75
Current Ratio	7.87	9.90	26.52	21.23	10.07	4.23
Asset Turnover	0.01	0.01	0.01	0.01	0	0.08
Interest Coverage	-706.31	-759.05	-1776.42	1295.01	-10.28	-15.10
Return on Equity (ROE)	-52.80%	-47.10%	-40.50%	36.80%	-230.40%	-1493.30%
Return on Assets (ROA)	-42.40%	-39.00%	-36.00%	30.90%	-181.90%	-187.10%
Return on Capital (ROIC)	-74.29%	-62.42%	-35.08%	-30.09%	-169.42%	-2386.69%
Earnings Yield	-103.21%	-82.67%	-37.06%	-	-	-
FCF Yield	-96.73%	-72.03%	-33.16%	-	-	-
Buyback Yield / Dilution	9.24%	-34.83%	-19.07%	-45.44%	-181.04%	52.20%
Total Shareholder Return	9.24%	-34.83%	-19.07%	-45.44%	-181.04%	52.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).